[Federal Register Volume 69, Number 120 (Wednesday, June 23, 2004)]
[Notices]
[Pages 35039-35040]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-14178]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Annual Influenza Vaccine Effectiveness Estimates 
in Healthy and High-Risk Populations, Program Announcement Number 04109

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Annual Influenza Vaccine Effectiveness 
Estimates in Healthy and High-Risk Populations, Program Announcement 
Number 04109.
    Times and Dates: 9 a.m.-9:30 a.m., July 26, 2004 (Open); 9:45 
a.m.-4 p.m., July 26, 2004 (Closed).
    Place: Marriott Airport Hotel, 4711 Best Road, College Park, GA 
30337, telephone 404-766-7900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement Number 04109.
    Contact Person for More Information: Trudy Messmer, Ph.D., 
Scientific Review Administrator, National Center for Infectious 
Diseases, CDC, 1600 Clifton Road, NE., MS-C19, Atlanta, GA 30333, 
telephone 404-639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


[[Page 35040]]


    Dated: June 17, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-14178 Filed 6-22-04; 8:45 am]
BILLING CODE 4163-18-P